Ustekinumab for moderate-to-severe Crohn's disease
- PMID: 23462132
- DOI: 10.1053/j.gastro.2013.02.030
Ustekinumab for moderate-to-severe Crohn's disease
Comment on
-
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Clinical Trial.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources